Citation Safe for Medical vs. Epocrates
Epocrates (athenahealth) is point-of-care drug reference: dosing, interactions, formulary lookup. Neither of you knows if the case is real. We do — and we publish our error rate.
Epocrates, now part of athenahealth, is a widely used point-of-care mobile app for drug information — dosing, interaction checking, formulary and insurance coverage lookups — free to clinicians with a paid tier for expanded content. It answers a fast clinical question at the bedside. Citation Safe for Medical answers a completely different question: whether the citations already written into a case report, literature review, or grant narrative are real, accurately quoted, and not retracted. This page exists mainly to clarify that these are not competing products.
| Comparison | Citation Safe | Epocrates (athenahealth) |
|---|---|---|
| Core function | Verifies medical literature citations already in a document, with retraction flagging | Point-of-care drug reference: dosing, interactions, formulary lookup |
| Free tier | 3 verifications/mo, no card | Yes, a well-established free tier for core drug-reference features |
| Checks a citation you already wrote against a primary source | Yes, deterministic, PubMed/Crossref/ClinicalTrials.gov | Not applicable — a drug-reference app, not a document-audit tool |
| Retraction cross-check on your own citation list | Yes | Not offered |
| Drug interaction and dosing lookup | Not offered | Yes — Epocrates' core, widely trusted function |
Different questions entirely
Epocrates answers "what's the right dose, and does this interact with that" in seconds at the point of care — a genuinely useful, widely adopted tool with a well-earned reputation among clinicians. It has no feature for checking whether the citations in a case report, manuscript, or grant application you've already written actually exist and are quoted accurately. That was never its job, and it is the entirety of Citation Safe for Medical's job.
Free tiers, different purposes
Both products offer a free tier, but they're free for different reasons and cover different use cases: Epocrates' free tier covers core drug-reference lookups that clinicians use daily at the bedside; Citation Safe for Medical's free tier (3 verifications/mo, no card) covers occasional document citation checks before a case report or grant narrative goes out. Neither free tier substitutes for the other.
Why this comparison exists at all
We publish this page because clinicians researching medical citation tools sometimes land on Epocrates by association with "trusted point-of-care medical app," then look for something that does the adjacent but distinct job of checking a document's citation list. If that's what you need, Epocrates doesn't do it — Citation Safe for Medical does, and the two apps solve genuinely different problems for the same clinician.
Bottom line
Epocrates is a trusted, free-first point-of-care drug reference; Citation Safe for Medical is a citation-verification tool for documents you've already written. A clinician can reasonably use both, for entirely different moments in their work.
Other comparisons
Frequently asked questions
Does Epocrates check citations in my case report or manuscript?
No — it's a point-of-care drug-reference app. Citation Safe for Medical is built specifically to verify citations already written into a separate document.
Is Epocrates free?
Yes, core drug-reference features are free, with a paid tier for expanded content — similar in spirit to Citation Safe for Medical's own free tier, though the two products do different jobs.
Does Citation Safe for Medical replace Epocrates for drug dosing or interaction checks?
No — we don't offer drug-reference features. We verify citations already present in a written document.
Verify your own brief in 30 seconds
Every citation checked against primary sources — free, no card required.
Try free →See our live accuracy scorecard
Our published false-verify rate, updated weekly — check it yourself.
See the live scorecard →Written by the Citation Safe Research Desk · Reviewed by Andy Gaber, Founder